Left Ventricular Diastolic Dysfunction in Type 2 Diabetes—Progress and Perspectives

• Published in: Diagnostics (Basel) Vol. 9; no. 3; p. 121
• Main Authors: Grigorescu, Elena-Daniela, Lacatusu, Cristina-Mihaela, Floria, Mariana, Mihai, Bogdan-Mircea, Cretu, Ioana, Sorodoc, Laurentiu
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 17.09.2019; MDPI
• Subjects: Biomarkers; Cardiomyocytes; Cardiomyopathy; Cardiovascular disease; Citations; Clinical medicine; Diabetes; diabetic cardiomyopathy; E/e’ index; echocardiography; Ejection fraction; Heart failure; Insulin resistance; left ventricular diastolic dysfunction; Metabolism; Patients; Review; type 2 diabetes
• ISSN: 2075-4418; 2075-4418
• DOI: 10.3390/diagnostics9030121

In-depth understanding of early cardiovascular manifestations in diabetes is high on international research and prevention agendas given that cardiovascular events are the leading cause of death for diabetic patients. Our aim was to review recent developments in the echocardiographic assessment of left ventricular diastolic dysfunction (LVDD) as a telltale pre-clinical disturbance preceding diabetic cardiomyopathy. We analyzed papers in which patients had been comprehensively assessed echocardiographically according to the latest LVDD guidelines (2016), and those affording comparisons with previous, widely used recommendations (2009). We found that the updated algorithm for LVDD is more effective in predicting adverse cardiovascular events in patients with established LVDD, and less specific in grading other patients (labelled “indeterminate”). This may prove instrumental for recruiting “indeterminate” LVDD cases among patients with type 2 diabetes mellitus (T2DM) in future screening programs. As an interesting consideration, the elevated values of the index E/e’ can point to early diastolic impairment, foretelling diabetic cardiomyopathy. Identifying subclinical signs early makes clinical sense, but the complex nature of T2DM calls for further research. Specifically, longitudinal studies on rigorously selected cohorts of diabetic patients are needed to better understand and predict the subtle, slow onset of cardiac manifestations with T2DM as a complicating backdrop.